169 related articles for article (PubMed ID: 35455475)
21. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
22. 5-amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a versatile scaffold to obtain potent and selective A3 adenosine receptor antagonists.
Da Settimo F; Primofiore G; Taliani S; Marini AM; La Motta C; Simorini F; Salerno S; Sergianni V; Tuccinardi T; Martinelli A; Cosimelli B; Greco G; Novellino E; Ciampi O; Trincavelli ML; Martini C
J Med Chem; 2007 Nov; 50(23):5676-84. PubMed ID: 17927167
[TBL] [Abstract][Full Text] [Related]
23. The role of receptor structure in determining adenosine receptor activity.
Olah ME; Stiles GL
Pharmacol Ther; 2000 Feb; 85(2):55-75. PubMed ID: 10722120
[TBL] [Abstract][Full Text] [Related]
24. New substituted 9-alkylpurines as adenosine receptor ligands.
Camaioni E; Costanzi S; Vittori S; Volpini R; Klotz KN; Cristalli G
Bioorg Med Chem; 1998 May; 6(5):523-33. PubMed ID: 9629466
[TBL] [Abstract][Full Text] [Related]
25. Structure activity relationships of 5-HT
Tosh DK; Calkins MM; Ivancich MS; Bock HA; Campbell RG; Lewicki SA; Chen E; Gao ZG; McCorvy JD; Jacobson KA
Eur J Med Chem; 2023 Nov; 259():115691. PubMed ID: 37562117
[TBL] [Abstract][Full Text] [Related]
26. Machine Learning for Discovery of New ADORA Modulators.
Puhl AC; Gao ZG; Jacobson KA; Ekins S
Front Pharmacol; 2022; 13():920643. PubMed ID: 35814244
[TBL] [Abstract][Full Text] [Related]
27. Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor.
Auchampach JA; Jin X; Wan TC; Caughey GH; Linden J
Mol Pharmacol; 1997 Nov; 52(5):846-60. PubMed ID: 9351976
[TBL] [Abstract][Full Text] [Related]
28. Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists.
Vazquez-Rodriguez S; Matos MJ; Santana L; Uriarte E; Borges F; Kachler S; Klotz KN
J Pharm Pharmacol; 2013 May; 65(5):697-703. PubMed ID: 23600387
[TBL] [Abstract][Full Text] [Related]
29. Development of novel pyridazinone-based adenosine receptor ligands.
Catarzi D; Varano F; Falsini M; Varani K; Vincenzi F; Pasquini S; Dal Ben D; Colotta V
Bioorg Med Chem Lett; 2018 May; 28(9):1484-1489. PubMed ID: 29627261
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and biological evaluation of 2-hydrazinyladenosine derivatives as A
Zhang M; Fan S; Zhou X; Xie F; Li S; Zhong W
Eur J Med Chem; 2019 Oct; 179():310-324. PubMed ID: 31255928
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and Evaluation of a New Series of 8-(2-Nitroaryl)Xanthines as Adenosine Receptor Ligands.
Bansal R; Kumar G; Rohilla S; Klotz KN; Kachler S; Young LC; Harvey AL
Drug Dev Res; 2016 Aug; 77(5):241-50. PubMed ID: 27404511
[TBL] [Abstract][Full Text] [Related]
32. Adenosine Receptor Ligands: Coumarin-Chalcone Hybrids as Modulating Agents on the Activity of
Vazquez-Rodriguez S; Vilar S; Kachler S; Klotz KN; Uriarte E; Borges F; Matos MJ
Molecules; 2020 Sep; 25(18):. PubMed ID: 32961824
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and biological activity of N6-substituted-4'-thioadenosines at the human A3 adenosine receptor.
Jeong LS; Lee HW; Kim HO; Jung JY; Gao ZG; Duong HT; Rao S; Jacobson KA; Shin DH; Lee JA; Gunaga P; Lee SK; Jin DZ; Chun MW; Moon HR
Bioorg Med Chem; 2006 Jul; 14(14):4718-30. PubMed ID: 16603368
[TBL] [Abstract][Full Text] [Related]
34. 7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: structural investigations at the 5-position to target human A₁ and A(2A) adenosine receptors. Molecular modeling and pharmacological studies.
Squarcialupi L; Colotta V; Catarzi D; Varano F; Betti M; Varani K; Vincenzi F; Borea PA; Porta N; Ciancetta A; Moro S
Eur J Med Chem; 2014 Sep; 84():614-27. PubMed ID: 25063944
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of N-substituted 2-amino-4,5-diarylpyrimidines as selective adenosine A
Alachouzos G; Lenselink EB; Mulder-Krieger T; de Vries H; IJzerman AP; Louvel J
Eur J Med Chem; 2017 Jan; 125():586-602. PubMed ID: 27718474
[TBL] [Abstract][Full Text] [Related]
36. The Influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl Moiety on the Adenosine Receptors Affinity Profile of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine Derivatives.
Federico S; Redenti S; Sturlese M; Ciancetta A; Kachler S; Klotz KN; Cacciari B; Moro S; Spalluto G
PLoS One; 2015; 10(12):e0143504. PubMed ID: 26625265
[TBL] [Abstract][Full Text] [Related]
37. Exploring the Role of N
Petrelli R; Scortichini M; Kachler S; Boccella S; Cerchia C; Torquati I; Del Bello F; Salvemini D; Novellino E; Luongo L; Maione S; Jacobson KA; Lavecchia A; Klotz KN; Cappellacci L
J Med Chem; 2017 May; 60(10):4327-4341. PubMed ID: 28447789
[TBL] [Abstract][Full Text] [Related]
38. 3-Aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: a new class of selective A1 adenosine receptor antagonists.
Da Settimo F; Primofiore G; Taliani S; Marini AM; La Motta C; Novellino E; Greco G; Lavecchia A; Trincavelli L; Martini C
J Med Chem; 2001 Feb; 44(3):316-27. PubMed ID: 11462973
[TBL] [Abstract][Full Text] [Related]
39. A Taxicab geometry quantification system to evaluate the performance of in silico methods: a case study on adenosine receptors ligands.
Kuder KJ; Michalik I; Kieć-Kononowicz K; Kolb P
J Comput Aided Mol Des; 2020 Jun; 34(6):697-707. PubMed ID: 32112287
[TBL] [Abstract][Full Text] [Related]
40. 1-substituted 4-[chloropyrazolyl][1,2,4]triazolo[4,3-a]quinoxalines: synthesis and structure-activity relationships of a new class of benzodiazepine and adenosine receptor ligands.
Matuszczak B; Pekala E; Müller CE
Arch Pharm (Weinheim); 1998 May; 331(5):163-9. PubMed ID: 9691247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
